Pharmaceutical / Drug Definition :
Thought to interfere with bacterial cell-wall synthesis by cross-linking strands of DNA and disrupting RNA transcription, causing cell to rupture and die. Exhibits minimal immunosuppressant activity.
In the United States, Carmustine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Carmustine.
Registrar Corp assists Carmustine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Carmustine (Carmustine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Carmustine (Carmustine Suppliers)
- Processors Carmustine
- Repackers Carmustine
- Relabelers Carmustine
- Exporters Carmustine
- Importers Carmustine
For more information about Carmustine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.